30 Day Trial

Orthofix Up +3.9% in 2Q19 on Biologics Outperformance

Share:

Orthofix reports 2Q19 revenue of USD $115.9MM, +3.9% vs. 2Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.